Jump Financial’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
Jump Financial's ARCT Position: Q3 2026 in Review
Jump Financial reduced its Arcturus Therapeutics (ARCT) stake by 78% in Q3 2026, selling an estimated $1.13M and leaving 29,879 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.
Jump Financial first reported a position in ARCT in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.46M in Q1 2021. 155 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.
- Jump Financial held 29,879 shares of Arcturus Therapeutics worth $409K as of Q3 2026.
- Jump Financial sold 108,330 Arcturus Therapeutics shares in Q3 2026, an estimated $1.13M.
- Arcturus Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #1798 holding.
- Jump Financial first reported a position in Arcturus Therapeutics in Q1 2021 and has held it in 12 quarters since.
- Jump Financial's Arcturus Therapeutics position peaked at $1.46M in Q1 2021.
- 155 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.